<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04706650</url>
  </required_header>
  <id_info>
    <org_study_id>muğla sıtkı koçman university</org_study_id>
    <nct_id>NCT04706650</nct_id>
  </id_info>
  <brief_title>Exercise Capacity, Cardiovascular Risk Factors and Disease-related Variables in Axial Spondyloarthritis</brief_title>
  <official_title>Exercise Capacity in Axial Spondyloarthritis and Factors Affecting it: a Cross-sectional Controlled Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Muğla Sıtkı Koçman University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Muğla Sıtkı Koçman University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators aimed to study the associations between exercise capacity and&#xD;
      cardiovascular (CV) risk factors in axial spondyloarthritis (axSpA) patients and to determine&#xD;
      possible relationships with disease-related variables. Thirty eight patients and 38 controls&#xD;
      were recruited in our cross-sectional controlled study. Comprehensive systemic and&#xD;
      musculoskeletal examinations were carried out in both of the groups. Cardiovascular risk&#xD;
      profile data, ASDAS-CRP, 10-year CV event risk, physical activity levels (IPAQ) were&#xD;
      recorded. A maximal treadmill exercise test by Bruce protocol was administered to all&#xD;
      participants.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">May 15, 2014</start_date>
  <completion_date type="Actual">October 15, 2014</completion_date>
  <primary_completion_date type="Actual">October 15, 2014</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Mean difference in exercise capacity of axSpA patients and controls</measure>
    <time_frame>may- october 2014</time_frame>
    <description>maximal METs achieved by a maximal treadmill test by Bruce protocol</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Mean difference in heart rate recovery of axSpA patients and controls</measure>
    <time_frame>may- october 2014</time_frame>
    <description>peak heart rate achieved by maximal exercise minus heart rate at 1st minute of recovery phase</description>
  </secondary_outcome>
  <enrollment type="Actual">76</enrollment>
  <condition>Exercise Capacity</condition>
  <condition>Axial Spondyloarthritis</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Thirty eight patients fulfilling the ASAS axial SpA criteria were recruited from the&#xD;
        department of Gazi University Physical Medicine and Rehabilitation Rheumatology. 38 control&#xD;
        subjects were randomly recruited from local hospital staff with a similar range of sex and&#xD;
        age to the patients.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  clinical diagnosis of axial SpA&#xD;
&#xD;
          -  must be able to walk&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  established cardiac disease including structural heart diseases,&#xD;
&#xD;
          -  uncontrolled hypertension,&#xD;
&#xD;
          -  cardiac rhythm disorder,&#xD;
&#xD;
          -  unstable angina pectoris,&#xD;
&#xD;
          -  chronical renal and/or hepatic disease,&#xD;
&#xD;
          -  malignancy,&#xD;
&#xD;
          -  neuromuscular disease&#xD;
&#xD;
          -  musculoskeletal deformity&#xD;
&#xD;
          -  the history of an inflammatory arthritis for control group&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>January 5, 2021</study_first_submitted>
  <study_first_submitted_qc>January 10, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">January 13, 2021</study_first_posted>
  <last_update_submitted>January 10, 2021</last_update_submitted>
  <last_update_submitted_qc>January 10, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 13, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Muğla Sıtkı Koçman University</investigator_affiliation>
    <investigator_full_name>Ebru Koseoglu Tohma</investigator_full_name>
    <investigator_title>specialist medical doctor</investigator_title>
  </responsible_party>
  <keyword>axial spondyloarthritis</keyword>
  <keyword>exercise capacity</keyword>
  <keyword>cardiovascular risk factors</keyword>
  <keyword>nonradiographic axial spondyloarthritis</keyword>
  <keyword>cardiorespiratory fitness</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Spondylarthritis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

